Cargando…
Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma
Chibby is an antagonist of β-catenin and is considered a potential tumor suppressor protein, but the role of Chibby in hepatocellular carcinoma (HCC) has not been characterized. The expression patterns of Chibby and β-catenin in HCC specimens and paired adjacent noncancerous tissues were measured by...
Autores principales: | Tsai, Ming-Chao, Huang, Chao-Cheng, Wei, Yu-Ching, Liu, Ting-Ting, Lin, Ming-Tsung, Yi, Li-Na, Lin, Pey-Ru, Wang, Chih-Chi, Chu, Tian-Huei, Hsiao, Chang-Chun, Hu, Tsung-Hui, Tai, Ming-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139567/ https://www.ncbi.nlm.nih.gov/pubmed/32192213 http://dx.doi.org/10.3390/ijms21062060 |
Ejemplares similares
-
Nuclear-Cytoplasmic Shuttling of Chibby Controls β-Catenin Signaling
por: Li, Feng-Qian, et al.
Publicado: (2010) -
Downregulation of nuclear and cytoplasmic Chibby is associated with advanced cervical cancer
por: Yang, Ming-Chang, et al.
Publicado: (2017) -
Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia
por: Mancini, Manuela, et al.
Publicado: (2017) -
Chibby cooperates with 14-3-3 to regulate β-catenin subcellular distribution and signaling activity
por: Li, Feng-Qian, et al.
Publicado: (2008) -
Chibby’s function in the dock
por: Short, Ben
Publicado: (2014)